AXONICS INC (AXNX)
US05465P1012 - Common Stock
Boston Scientific Announces Results for First Quarter 2024
/PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) generated net sales of $3.856 billion during the first quarter of 2024, growing 13.8 percent on a...
Noteworthy Thursday Option Activity: AXNX, ABBV, ROKU
Axonics Stockholders Approve Merger Agreement with Boston Scientific
Axonics Receives CE Mark Approval for Fourth-Generation Rechargeable Sacral Neuromodulation System
Notable Friday Option Activity: PFE, AXNX, TEAM
Boston Scientific Likely Faces FTC Scrutiny on $3.7 Billion Axonics Deal
Boston Scientific Corp.’s proposed $3.7 billion acquisition of medical device maker Axonics Inc. will likely be scrutinized by the US Federal Trade Commission because the companies are the dominant providers of some treatments for urinary incontinence, according to antitrust experts.
Medtronic accuses Axonics of patent infringement, files ITC complaint (NASDAQ:AXNX)
Medtronic (MDT) has filed a complaint with the US International Trade Commission and a U.S. District Court accusing Axonics (AXNX) of patent infringement. Read more here.
Axonics Responds to ITC Action by Medtronic
Axonics Reports Fourth Quarter and Fiscal Year 2023 Financial Results
SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates AXNX, JNPR, MDC
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates CTLT, AXNX, BATL, APA
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
INVESTIGATION ALERT: Halper Sadeh LLC Investigates AXNX, AMAM, FGH
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
Boston Scientific Announces Results for Fourth Quarter and Full Year 2023
/PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) generated net sales of $3.725 billion during the fourth quarter of 2023, growing 14.9 percent on a...
SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates RYZB, FGH, AXNX, AMAM
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates FGH, AMAM, AXNX
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
SHAREHOLDER RIGHTS INVESTIGATION: Halper Sadeh LLC Investigates AMAM, AXNX, HARP, GRCL
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
Stock Market Rally Rebounds; Nvidia, Tesla, JPMorgan, Bitcoin ETFs In Focus: Weekly Review
The major indexes and leading stocks rebounded. Bitcoin ETFs fell in their debut.
Kuehn Law Encourages AMAM, HARP, AXNX, and CPE Investors to Contact Law Firm
/PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating potential claims related to the below-listed proposed mergers. Kuehn Law...
10 Top Stocks With a Strong Buy Rating Right Now
Wall Street is highly bullish on these strong buy stocks, even as financial markets face an uncertain year. Here are the names to watch.
Why Axonics Stock Soared Today
The medical device maker agreed to be acquired by Boston Scientific.
ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Axonics, Inc.
/PRNewswire/ -- Rowley Law PLLC is investigating potential securities law violations by Axonics, Inc. (NASDAQ: AXNX) and its board of directors concerning the...
J&J, Merck and Boston Scientific Go on $6.4 Billion Buying Spree
More than $6.4 billion in health-care deals were announced on Monday at the annual JPMorgan Healthcare Conference in San Francisco as companies like Johnson & Johnson and Merck & Co. look to acquisitions to replenish their revenue streams.
Why Is Crocs (CROX) Stock Up 20% Today?
Crocs stock is heading higher on Monday with heavy trading of CROX shares after the company posted a strong outlook for 2024!
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates HARP, AMAM, AXNX
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
Why Is Axonics (AXNX) Stock Up 20% Today?
Axonics stock is rising higher on Monday as investors react to a $71 per share cash offer for AXNX stock from Boston Scientific.
Why Is Axonics (AXNX) Stock Up 20% Today?
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Axonics (NASDAQ:AXNX) stock is rising higher on Monday following news that Bost...
Shareholder Alert: Ademi LLP investigates whether Axonics, Inc. has obtained a Fair Price in its transaction with Boston Scientific
/PRNewswire/ -- Ademi LLP is investigating Axonics (Nasdaq: AXNX) for possible breaches of fiduciary duty and other violations of law in its transaction with...
J&J, Merck, Boston Scientific Debut Trio Of Splashy Takeovers Topping $3 Billion In Value
The year's biggest medical conference kicked off with a melee of buyout news.
